Qiuxiang Ou
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Molecular Biology
- Cancer Research top 5%
- Cellular and Molecular Neuroscience top 10%
- Topics
- Cancer Genomics and Diagnostics (52 papers)Lung Cancer Treatments and Mutations (43 papers)Lung Cancer Research Studies (19 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Qiuxiang Ou
97 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Pulmonary and Respiratory Medicine 890
- Oncology 794
- Molecular Biology 655
- Cancer Research 419
- Cellular and Molecular Neuroscience 252
Countries citing papers authored by Qiuxiang Ou
This map shows the geographic impact of Qiuxiang Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuxiang Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuxiang Ou more than expected).
Fields of papers citing papers by Qiuxiang Ou
This network shows the impact of papers produced by Qiuxiang Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuxiang Ou. The network helps show where Qiuxiang Ou may publish in the future.
Co-authorship network of co-authors of Qiuxiang Ou
This figure shows the co-authorship network connecting the top 25 collaborators of Qiuxiang Ou. A scholar is included among the top collaborators of Qiuxiang Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuxiang Ou. Qiuxiang Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 0 | |
| 9 | 4 | |
| 10 | 10 | |
| 11 | 2 | |
| 12 | 5 | |
| 13 | 3 | |
| 14 | 3 | |
| 15 | 1 | |
| 16 | 40 | |
| 17 | 3 | |
| 18 | 17 | |
| 19 | 26 | |
| 20 | Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patientsbreakdown → | 390 |
About Qiuxiang Ou
Qiuxiang Ou is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 112 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (52 papers), Lung Cancer Treatments and Mutations (43 papers) and Lung Cancer Research Studies (19 papers). The work is most often cited by research in Oncology (794 citations), Cancer Research (419 citations) and Pulmonary and Respiratory Medicine (890 citations). Qiuxiang Ou has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xue Wu, Kirst King‐Jones, Yang Shao, Hua Bao, Xiaonan Wang, Xiaoling Tong, Caicun Zhou, Yi Xiang, Nong Yang and Tao Jiang. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.